SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001455244-11-000025
Filing Date
2011-05-18
Accepted
2011-05-18 10:39:45
Documents
1
Period of Report
2011-05-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4746
  Complete submission text file 0001455244-11-000025.txt   6406
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Issuer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NABI BIOPHARMACEUTICALS 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address
Kessler Paul D. (Reporting) CIK: 0001428524 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-04829 | Film No.: 11853716